In The News Posted March 1, 2019 Share Posted March 1, 2019 YORBA LINDA, Calif., March 1, 2019 /PRNewswire/ -- Liveyon, the global leader in regenerative medicine, today announced the availability of Liveyon PURE® trial grade stem cell concentrate derived from umbilical cord blood. Manufactured at Liveyon Labs, the company's own FDA -registered... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.